Hear it from the pulpit, on this occasion set up at The Royal Society:

Disclosure (from today’s blogger): Professor Coles chairs the DMEC of ChariotMS (NCT04695080), a trial of cladribine in people with advanced MS, which is supported by the MS Society as part of their StopMS programme.

Source: multiple-sclerosis-research.org